TRPV1 receptor blockade is ineffective in different in vivo models of migraine (Q42679624)

4 November 2017

TRPV1 receptor blockade is ineffective in different in vivo models of migraine (English)

1 reference

4 November 2017

1 reference

4

Peter J Goadsby

1 reference

4 November 2017

3

Simon Akerman

1 reference

4 November 2017

Oliver Summ

1

1 reference

PubMed ID

20974587

4 November 2017

Philip R Holland

series ordinal

2

1 reference

PubMed ID

20974587

4 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

4 November 2017

1 reference

4 November 2017

31

1 reference

4 November 2017

2

1 reference

4 November 2017

172-180

1 reference

The global burden of disease study: implications for neurology

4 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Cost of disorders of the brain in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Migraine--current understanding and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

The pharmacology of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Emerging therapies for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

The cloned capsaicin receptor integrates multiple pain-producing stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

21 January 2018

Thermosensation and pain

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Painful toxins acting at TRPV1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Animal models of migraine: looking at the component parts of a complex disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Pathophysiology of the migraine aura. The spreading depression theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Ethical guidelines for investigations of experimental pain in conscious animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Capsaicin receptor immunoreactivity in the human trigeminal ganglion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Distribution and origin of TRPV1 receptor-containing nerve fibers in the dura mater of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

[3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Electrophysiological and morphological properties of neurons in the substantia gelatinosa of the mouse trigeminal subnucleus caudalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Suppression of cortical spreading depression in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Transient receptor potential vanilloid type 1 receptor regulates glutamatergic synaptic inputs to the spinothalamic tract neurons of the spinal cord deep dorsal horn

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

TRPV1 antagonist, SB-366791, inhibits glutamatergic synaptic transmission in rat spinal dorsal horn following peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102410375626

21 January 2018

Identifiers

DOI

10.1177/0333102410375626

1 reference

4 November 2017

1 reference

PubMed ID

20974587